Japan Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare)
|
Major Players
|
Japan Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in Japan was valued at USD 1.37 billion in 2025 and is estimated at USD 1.39 million in 2026.
- The market size is expected to grow to USD 1.53 billion by 2032.
- Market to register a CAGR of around 1.59% during 2026-32.
- Product Shares
- Topical analgesics/anaesthetic grabbed market share of 55%.
- Competition
- More than 10 companies are actively engaged in producing analgesics in Japan.
- Top 5 companies acquired around 55% of the market share.
- Taisho Pharmaceutical Co Ltd, Shionogi Healthcare Co Ltd, Arax Co Ltd, Hisamitsu Pharmaceutical Co Inc, SSP Co Ltd etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 90% of the market.
Japan Analgesics Market Outlook
The Japan analgesics market size was valued at USD 1.37 billion in 2025 and is projected to grow from USD 1.39 billion in 2026 to USD 1.53 billion by 2032, exhibiting a CAGR of around 1.59% during the forecast period. The increasing self medication is also contributing to growth, with more consumers treating minor pain, headaches, and fever independently before seeking clinic care. Customers are also becoming more conscious of ingredients, side effects, and clearer usage instructions, which is contributing to a stable demand of OTC pain relief products.
The demand is not going to decrease since a significant portion of the population is older and continues to lead an active life. In 2025, people aged 65 and above reached 36.19 million, accounting for 29.4% of the total population, while 9.30 million people in this age group were employed. This advocates the routine administration of analgesics in the management of daily pain. Meanwhile, the category is under pressure due to the declining population in Japan, which restricts the growth of volume in the long term.
By product type, topical analgesics/anaesthetic holds the highest share at around 55%. This leadership is backed by high demand of gels, sticks, plasters, and cooling formats that provide specific relief to muscle, joint, shoulder, and lower back pain. These products are aligned with the trend towards symptom specific self care and are popular due to their convenience and ease of use.
By sales channel, retail offline leads with around 90% share, supported by strong consumer trust in pharmacies and drugstores. These stores allow buyers to easily compare analgesics, read labels, and choose products according to ingredients, safety, and intended use. The broader switch OTC environment and policy favoring self managed care are also providing additional space in which trusted pain relief products can grow in the coming years via offline retailing.

Japan Analgesics Market Growth DriverSelf-Care Gains Stronger Ground
Increasing self medication is favoring the demand of analgesics in Japan. Consumers are increasingly treating minor pain, headaches, and fever independently before going to a clinic, particularly as they become more attentive to ingredients, side effects, and more explicit usage instructions. This change is favoring acetaminophen based products as many consumers are viewing them as a safer alternative to daily pain treatment, and OTC usage is still closely associated with self care.
This trend is supported by the ageing profile of Japan. The Statistics Bureau reports that the population aged 65 and over reaches 36.19 million in 2025, accounting for 29.4% of the total population, the highest share on record. According to the same source, there are also 9.30 million individuals aged 65 and above who are working in 2025. The high and active elderly population maintains the demand constant on the availability of pain management products that are used in everyday life.
Japan Analgesics Market ChallengePopulation Shrinkage Limits Category Expansion
The falling population is one of the major challenges analgesics is facing in Japan. Although the demand in self care may remain strong, a reduced number of consumers complicates the overall growth of the category in the long run. This puts pressure on businesses to depend more on targeted pain segments, premium formats, and greater differentiation as opposed to depending solely on broader volume growth among the entire population.
This pressure is evident in official data. According to the Statistics Bureau, the total population of Japan is 123.219 million on 1 October 2025, a decrease of 583,000 compared to a year ago. It also reports that the population under the age of 15 years reduces to 13.469 million, which is a decrease of 361,000 per annum. An ageing and declining population slows the rate of natural consumer base growth and makes long term volume growth more limited to analgesics.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Japan Analgesics Market TrendTopical Formats Gain Stronger Preference
Topical analgesics are emerging as a trend in Japan. Gels, sticks, plasters, and cooling formats of muscle and joint pain are becoming more popular among consumers due to their ease of application, increased targeting, and more appropriate application to particular situations. It is also pushing companies to introduce more customized formats that enhance convenience and assist buyers to make more confident choices on products depending on symptoms and ease of use.
This shift is supported by activity led demand. Japan National Tourism Organization (JNTO) reports 42.68 million visitor arrivals in Japan in 2025, up 15.8% from 2024. According to the Statistics Bureau, 9.30 million employed individuals aged 65 and above are also reported in 2025, which indicates that active seniors are still a significant population in the country. The increased travel and the active aging population continue to make the topical analgesics that help in everyday relief of joint, muscle, shoulder, and lower back pain in demand.
Japan Analgesics Market OpportunitySwitch OTC Expansion Creates New Space
A wider switch OTC environment provides a good opening in Japan. Self managed care is being supported by policy, which is enhancing access to more non prescription products and this provides companies with more space to promote trusted pain relief products via retailing. Enhanced product information, improved ingredient communication, and enhanced everyday care positioning are gaining significance as consumers increasingly become more active participants in minor pain management.
The policy base is already considerable. According to the Ministry of Health, Labour and Welfare, the self medication tax system is prolonged by five years since January 2022 and the range of eligible products is increased. The switch OTC list contains 2,977 items as of 1 March 2026. In this list, ibuprofen represents 356 items, loxoprofen represents 267, and diclofenac represents 152. This provides manufacturers of analgesics with a broader product development and consumer base.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Japan Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the product type category is topical analgesics/anaesthetic, accounting for around 55% of the Japan analgesics market. This high standing is due to the increasing consumer preference of specific pain reliever to muscle pain, joint pain, shoulder stiffness, and lower back pain. These products are simple to use and are popular among ageing consumers and active adults seeking convenient self care products.
The increasing range of formats including gels, sticks, cooling patches, and plasters also contribute to its leadership as they enhance comfort and usability. There is also an increased concern about the ingredients of the products, safety and ease of use, which is contributing to the increased acceptance of topical products. This segment will continue to be the most dominant section of the market in 2026-32 as self medication gains popularity in Japan.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the sales channel category is retail offline, holding around 90% of the Japan analgesics market. Its leadership is largely anchored on high consumer confidence in the physical stores where customers can easily compare products, read labels, and buy them on the spot to alleviate pain immediately. Pharmacies and drugstores are still the most favored points of purchase, particularly in OTC analgesics that are used to treat daily aches, headaches, and joint pain.
The high store based healthcare retail network in Japan and the tendency to purchase medicines in local stores are also an advantage of this sales channel. Physical stores facilitate increased product awareness and enable consumers to make decisions based on ingredients, safety, and purpose. Since the demand of analgesics is still associated with self medication and regular healthcare purchases, retail offline is likely to keep dominating the market in 2026-32.
List of Companies Covered in Japan Analgesics Market
The companies listed below are highly influential in the Japan analgesics market, with a significant market share and a strong impact on industry developments.
- Taisho Pharmaceutical Co Ltd
- Shionogi Healthcare Co Ltd
- Arax Co Ltd
- Hisamitsu Pharmaceutical Co Inc
- SSP Co Ltd
- Daiichi Sankyo Healthcare Co Ltd
- Lion Corp
- Kowa Co Ltd
- Sato Pharmaceutical Co Ltd
- Kobayashi Pharmaceutical Co Ltd
Competitive Landscape
In 2025, the analgesics market in Japan was led by Hisamitsu Pharmaceutical Co Inc, which maintained its leadership through strong performance in topical analgesics, supported by its well-established Salonpas brand and continued innovation in high-value products despite price increases, while SSP Co Ltd ranked second, driven by the sustained popularity and strategic positioning of its Eve brand, with both companies benefiting from the growing consumer shift towards self-medication, preference for topical and targeted pain relief solutions, and increasing demand for high-performance OTC products amid rising healthcare costs.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Japan Analgesics Market Policies, Regulations, and Standards
- Japan Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Japan Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- Japan Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Japan Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- Hisamitsu Pharmaceutical Co Inc
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- SSP Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Daiichi Sankyo Healthcare Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Lion Corp
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Kowa Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Taisho Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Shionogi Healthcare Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Arax Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Sato Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Kobayashi Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Hisamitsu Pharmaceutical Co Inc
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











